Zai Lab

ZLABNasdaq China Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.620 B

$23.32 +11.69%

Close of 7 Aug 2026

Revenue

$460.2M

#1955 by revenue

Earnings

-$175.5M

Loss-making

Shares outstanding

1,122,445,390

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#86Nurix TherapeuticsNRIX$2.65B
#87Trevi TherapeuticsTRVI$2.63B
#88Zai LabZLAB$2.62B
#89Prestige Consumer HealthcarePBH$2.60B
#90PrecigenPGEN$2.59B

Where these numbers come from

Share counts and financials for Zai Lab are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.